MEDEZE Affirms Leadership in Stem Cell Banking

MGR Online•Economy•2d ago

Reader Briefing

MEDEZE Group develops comprehensive stem cell and advanced therapy medical infrastructure under international standards.

•MEDEZE Group is the first and only cell bank in Thailand to pass the cell banking standards.
•MEDEZE Group has received a current medicine production license (Ph.Y.2) from the Food and Drug Administration.
•MEDEZE Group is participating in the Advanced Therapy Medicinal Products (ATMPs) Regulatory Sandbox.

•MEDEZE Group is the first cell bank in Thailand to pass the cell banking standards as per the Department of Medical Sciences and Ministry of Public Health regulations.
•MEDEZE Group obtained a current medicine production license (Ph.Y.2) from the Food and Drug Administration for producing cell therapy products for clinical research.
•MEDEZE Group has received certifications from AABB and ISO, specifically ISO 9001:2015.
•MEDEZE Group joined the Advanced Therapy Medicinal Products (ATMPs) Regulatory Sandbox, a collaboration between the public sector, medical sector, and private sector.
•Dr. Weerapol Khemarangsan stated that MEDEZE Group aims to upgrade Thailand's potential to become a regional center for regenerative medicine and medical innovation.
•MEDEZE Group utilizes AXP AutoXpress Platform and Cryopreservation technology for cell separation and storage.
•MEDEZE Group provides storage for umbilical cord blood, umbilical cord tissue, fat, hair roots, and NK Cells.

Full article content is available on the original source.

Dr. Weerapol Khemarangsan

"We do not look at being only a stem cell storage provider, but want to create a comprehensive medical infrastructure for the future."

เราไม่ได้มองเพียงการเป็นผู้ให้บริการจัดเก็บสเต็มเซลล์ แต่ต้องการสร้างโครงสร้างพื้นฐานด้านการแพทย์แห่งอนาคตที่ครบวงจร

MEDEZE Group Public Company Limited(บริษัท เมดีซ กรุ๊ป จำกัด (มหาชน))

A company specializing in stem cell banking and regenerative medicine that is the first cell bank to pass standards in Thailand.

MEDEZE

The short name for MEDEZE Group Public Company Limited.

Food and Drug Administration(สำนักงานคณะกรรมการอาหารและยา)ℹ️

The government agency that granted the current medicine production license (Ph.Y.2) to MEDEZE Group.

Department of Medical Sciences(กรมวิทยาศาสตร์การแพทย์)

The agency whose cell banking standards were passed by MEDEZE Group.

Ministry of Public Health(กระทรวงสาธารณสุข)

The ministry that issued the regulations for cell banking standards announced in the Royal Gazette.

An international body that certified the standards of MEDEZE Group.

An international standards organization that certified MEDEZE Group, specifically ISO 9001:2015.

Stock Exchange of Thailand(ตลาดหลักทรัพย์แห่งประเทศไทย)ℹ️

The entity whose rules MEDEZE Group has complied with.

Dr. Weerapol Khemarangsan(นายแพทย์วีรพล เขมะรังสรรค์)

Chief Executive Officer of MEDEZE Group Public Company Limited.

Advanced Therapy Medicinal Products (ATMPs) Regulatory Sandbox

A collaborative project between public, medical, and private sectors to drive the development of advanced medical products in Thailand.